# Wave Life Sciences, Inc. (WVE) — domicile_change/redomiciliation [pending]
Source: SEC API (secapi.ai) · situation sit_88d66aa87b67c30f6004 · retrieved 2026-08-12T07:01:41.775Z

## Overview
Wave Life Sciences, Inc. is a pharmaceutical company that develops treatments using nucleic acid-based therapeutics; it is the parent company of Wave Life Sciences Ltd., a Singapore-incorporated public company previously listed on Nasdaq.

Wave Life Sciences, Inc., a Delaware corporation, became the ultimate parent company of the Wave Life Sciences group on August 7, 2026, pursuant to a scheme of arrangement under Singapore law. All issued ordinary shares of Wave Life Sciences Ltd. (the Singapore parent) were exchanged on a one-for-one basis for newly issued shares of Wave-Delaware common stock ($0.001 par value), and Wave-Singapore became a wholly owned subsidiary of Wave-Delaware. The issuance of Wave-Delaware Common Stock was exempt from registration under Section 3(a)(10) of the Securities Act of 1933. Wave-Singapore's ordinary shares were delisted from Nasdaq prior to August 10, 2026, and Wave-Delaware Common Stock began trading on Nasdaq under the same symbol "WVE" on August 10, 2026.

## Terms
- Counterparty: Wave Life Sciences Ltd. (Singapore) · Consideration: stock · Stake: 100%

## Key dates
- Announced 2026-08-07

## Timeline
- 2026-08-07 · 8-K12B (0001193125-26-340430): 8-K12B - Wave Life Sciences, Inc. — *Wave Life Sciences, Inc. is a pharmaceutical company that develops treatments using nucleic acid-based therapeutics; it is the parent company of Wave Life Sciences Ltd., a Singapore-incorporated public company previously listed on Nasdaq.* Wave Life Sciences, Inc., a Delaware corporation, became the ultimate parent company of the Wave Life Sciences group on August 7, 2026, pursuant to a scheme of arrangement under Singapore law. All issued ordinary shares of Wave Life Sciences Ltd. (the Singapore parent) were exchanged on a one-for-one basis for newly issued shares of Wave-Delaware common stock ($0.001 par value), and Wave-Singapore became a wholly owned subsidiary of Wave-Delaware. The issuance of Wave-Delaware Common Stock was exempt from registration under Section 3(a)(10) of the Securities Act of 1933. Wave-Singapore's ordinary shares were delisted from Nasdaq prior to August 10, 2026, and Wave-Delaware Common Stock began trading on Nasdaq under the same symbol "WVE" on August 10, 2026.
  https://www.sec.gov/Archives/edgar/data/1631574/0001193125-26-340430.txt

## Citations
- 0001193125-26-340430 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000119312526340430